Lv1
30 积分 2026-06-06 加入
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
11小时前
已完结
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer
13小时前
已完结
Ultrasound-induced cascade nanozyme catalysis for enhanced tumor cell pyroptosis and systemic anti-tumor immunity
1个月前
已完结
Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%
1个月前
已完结
Continuation of immunotherapy beyond progression is beneficial to the survival of advanced non-small-cell lung cancer
1个月前
已完结
Outcomes and Treatments of Patients With Non–Small Cell Lung Cancer Who Received Pembrolizumab
4个月前
已完结
皖公网安备34019202002308
